Celularity Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Celularity Inc.
Former names: GX Acquisition Corp.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Florham Park
Headquarters state / province: New Jersey
Headquarters country: United States
Fiscal year end: December
Ticker symbol: CELU
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001752828
EIN: 83-1702591

Board of directors

Follow this board

Dean C. Kehler · Director
Since 2023
Diane L. Parks · Director
Since 2023
Eschenbach Andrew C. Von · Director
Since 2023
Geoffrey Ling M.D. · Director
Since 2023
John Sculley · Director
Since 2023
Kok Thay Lim · Director
Since 2023
Marc Mazur · Director
Since 2023
Peter Diamandis · Director
Since 2023
Philip Alan Barach · Director
Since 2026
Richard J. Berman · Director Overboarded
Since 2024
Robert J. Hariri · Director · Chief Executive Officer
Since 2023
Robin L. Smith · Director
Since 2023
Vincent LeVien · Director
Since 2025

Chief executives

Robert J. Hariri · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of December 19, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 14 other boards. 8 are in the same sector.

Shared director Other board Same sector

BioVie Inc. Same sector
via Richard J. Berman and Robert J. Hariri
CryoPort Inc. Same sector
via Richard J. Berman and Robert J. Hariri
BCP Investment Corporation
via Dean C. Kehler
Bausch + Lomb Corporation Same sector
via Eschenbach Andrew C. Von
Context Therapeutics Inc. Same sector
via Richard J. Berman
Kura Oncology Inc. Same sector
via Diane L. Parks
Matinas Biopharma Holdings Inc. Same sector
via Robin L. Smith
Neostellar Capital Corp.
via Marc Mazur
NioCorp Developments Ltd.
via Dean C. Kehler
Sidus Space Inc.
via Richard J. Berman
Soligenix Inc. Same sector
via Diane L. Parks
Soren Acquisition Corp.
via Marc Mazur
TriSalus Life Sciences Inc. Same sector
via Eschenbach Andrew C. Von
Zeta Global Holdings Corp.
via John Sculley

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Apr 13, 2026	Brigido Stephen Officer (Pres., Functional Regeneration)	Option exercise	+821	—	—
Apr 13, 2026	Haines John R Officer (Senior Exec Vice President)	Option exercise	+1,641	—	—
Apr 13, 2026	Robert J. Hariri Director, Officer (Chief Executive Officer)	Option exercise	+3,281	—	—
Apr 13, 2026	Brigido Stephen Officer (Pres., Functional Regeneration)	Shares withheld for tax	−268	$1.28	$343
Apr 13, 2026	Haines John R Officer (Senior Exec Vice President)	Shares withheld for tax	−583	$1.28	$746
Apr 13, 2026	Robert J. Hariri Director, Officer (Chief Executive Officer)	Shares withheld for tax	−1,182	$1.28	$1,513
Jan 12, 2026	Geoffrey Ling M.D. Director	Grant or award	+19,231	—	—
Jan 12, 2026	Vincent LeVien Director	Grant or award	+28,847	—	—
Jan 12, 2026	Peter Diamandis Director	Grant or award	+20,385	—	—
Jan 12, 2026	Diane L. Parks Director	Grant or award	+30,000	—	—
Dec 29, 2025	Vincent LeVien Director	Grant or award	+125,000	—	—
Dec 29, 2025	Geoffrey Ling M.D. Director	Grant or award	+125,000	—	—
Dec 29, 2025	Diane L. Parks Director	Grant or award	+125,000	—	—
Dec 29, 2025	Peter Diamandis Director	Grant or award	+125,000	—	—
Dec 19, 2025	Diane L. Parks Director	Grant or award	+67,416	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Celularity Inc.

Who is the CEO of Celularity Inc.?

Robert J. Hariri is Celularity Inc.'s Chief Executive Officer.

How many directors are on Celularity Inc.'s board?

Celularity Inc.'s board has 13 directors: Dean C. Kehler, Diane L. Parks, Eschenbach Andrew C. Von, Geoffrey Ling M.D., John Sculley, Kok Thay Lim, Marc Mazur, Peter Diamandis, Philip Alan Barach, Richard J. Berman and 3 others.

How is Celularity Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="celularity-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.